High dosage of Rosuvastatin demonstrates robust lowering of TG levelsin high risk patients
Rosuvastatin demonstrates reduction in HF Hospitalization & small reduction in MI as per controlled multinational trials in heart failure(CORONA) & GISSI – HF trials